Vertex makes $10B deal for commercial endocrinology biotech Crinetics

July 6, 2026 04:27 PM EDTUpdated 04:54 PM DealsPharma Break­ing: Ver­tex makes $10B deal for com­mer­cial en­docrinol­o­gy biotech Cri­net­ics Kyle LaHucik Biotech Correspondent Ver­tex Phar­ma­ceu­ti­cals is mak­ing the largest ac­qui­si­tion in its his­to­ry, beef­ing up its com­mer­cial port­fo­lio with a $10 bil­lion takeover of Cri­net­ics Phar­ma­ceu­ti­cals. The Mon­day … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER